Standing Ovation Secures €30 Million to Expand Precision Fermentation Globally

Standing Ovation, a French company focused on precision fermentation, announced the successful completion of a €30 million Series B financing round. This round was co-led by the Ecotechnologies 2 fund, managed on behalf of the French government by Bpifrance under the France 2030 initiative, and Crédit Mutuel Innovation. The company’s existing investors, including Astanor, Bel Group, Seventure Partners, GoodStartUp, and Big Idea Ventures, participated alongside new investors such as Danone Ventures, Angelor, Newtree, and Noshaq.

The funding includes €25 million in equity and an additional €5 million in non-dilutive financing from Bpifrance and a leading banking syndicate. Standing Ovation is leveraging its patented technology to transform whey permeates into high-value caseins, which are in critical demand across the global agrifood industry. This innovative process involves upcycling agricultural sugars and milk whey, reducing the reliance on international supply chains and contributing to the industry's decarbonization efforts.

The company has protected its technology with eight patent families and claims that its process reduces greenhouse gas emissions by 74% and uses up to three times less water compared to traditional animal casein production. This funding will enable the commercial rollout of their proteins in the United States and, by the end of 2027, in Europe and Asia.

Yvan Chardonnens, CEO, and Romain Chayot, co-founder and Managing Director of Standing Ovation, emphasized the importance of their technology in driving an industry-wide shift towards sustainable, high-performance proteins. They aim to bridge the gap between the agrifood industry and deep tech, strengthening European food sovereignty.